“The philanthropic, for-profit, and government triad is an extremely valuable partnership that differentiates GHIT from lots of other organizations.”

Dr. Hannah Kettler

Senior Program Officer, Life Science Partnerships
Global Health Program, Office of the President
Bill & Melinda Gates Foundation

STAKEHOLDER INTERVIEWS

“By more directly linking Japanese techniques and craftsmanship to the type of global ideas and concepts embodied by GHIT, I think that we are certain to create great results.”

Mr. George Nakayama

Representative Director, Chairman and CEO
Daiichi Sankyo Company, Limited

STAKEHOLDER INTERVIEWS

“I believe that GHIT has catalyzed
a mindset shift for the Japanese
pharmaceutical industry
vis-à-vis global health R&D.”

Mr. Yoshihiko
Hatanaka

Representative Director,
President and CEO
Astellas Pharma Inc.

STAKEHOLDER
INTERVIEWS

“After all, people cannot address problems of which they are unaware”

SPONSOR INTERVIEWS

NEWSJourney with us through GHIT’s Past and Future

  • 2017.05.10 NEWS New interview articles have been released
  • 2017.04.10 NEW SITE OPEN NEW GHIT Fund 5th Anniversary Website Launched

GHIT FUND HISTORYOur first 5 years (2013-2017)

GHIT FUND FUTUREPlans for the next 5 years (2018-2022)

Coming June 2017

STAKEHOLDER INTERVIEWSPerspectives from 15 global health leaders on
GHIT's catalytic role and Japan's transformational
contributions to global health R&D

FUNDING

Dr. Naoko YamamotoAssistant Minister for Global Health
Minister's Secretariat
Ministry of Health, Labour and Welfare
Dr. Hannah KettlerSenior Program Officer, Life Science Partnerships
Global Health Program, Office of the President
Bill & Melinda Gates Foundation

Available in August 2017

Prof. Stephen CaddickWellcome Trust

DISCOVERY

Dr. David ReddyCEO
Medicine for Malaria Venture (MMV)
Mr. George NakayamaRepresentative Director, Chairman and CEO
Daiichi Sankyo Company, Limited

Available in June 2017

Prof. Kiyoshi KitaProfessor Emeritus, The University of Tokyo
Professor and Dean, Nagasaki University School of Tropical Medicine and Global Health

DEVELOPMENT

Mr. Christophe WeberRepresentative Director, President and CEO
Takeda Pharmaceutical Company Limited
Mr. Yoshihiko HatanakaRepresentative Director, President and CEO
Astellas Pharma Inc.

Available in July 2017

Dr. Nathalie Strub WourgaftMedical Officer
Drugs for Neglected Diseases initiative (DNDi)

ACCESS

Available in June 2017

Dr. Jayasree K. IyerExecutive Director
Access to Medicine Foundation

Available in July 2017

Mr. Tetsuo KondoDirector
UNDP Representation Office in Tokyo

Available in August 2017

Dr. Aya YajimaTechnical Officer
Malaria, other Vectorborne and Parasitic Diseases Unit
Division of Communicable Diseases
World Health Organization Western Pacific Regional Office

POLICY

Available in June 2017

Dr. Mark DybulExecutive Director
Global Fund

Available in July 2017

Dr. Seth BerkleyCEO
Gavi

Available in August 2017

Hon. Prof. Keizo TakemiMember of the House of Councillors of Japan
Chairman, Special Committee onGlobal Health Strategy
of the Liberal Democratic Party's Policy

SPONSOR INTERVIEWSOur shared vision drives creative partnerships for global health innovation

All Nippon Airways
Yahoo! JAPAN
salesforce.com Co.,Ltd.

Available in June 2017

MORRISON FOERSTER

Available in July 2017

Mori Building Co., Ltd.

Available in August 2017

STAFF STORYDiverse paths lead to global health R&D

Coming Fall 2017